Effects of Ground-based Walking Training in Pulmonary Hypertension

NCT03762577 | Completed

• 1 other identifier: 30146
• Study Type: interventional
• Target: 24
• Locations: 1 country
• Sites: 1

Brief Summary

Pulmonary Hypertension (PH) is a hemodynamic and physiopathological condition that is defined as an increase in pulmonary artery pressure ≥25 mmHg when measured at resting with symptoms such as dyspnea, fatigue, chest pain, and syncope. PH characterized by decreased exercise capacity, quality of life, peripheral muscle strength, balance, and physical inactivity. It is recommended that patients with PH should be included in cardiopulmonary rehabilitation programs in addition to medical treatment. Ground-based walking training is a safe and effective method for COPD patients. In the literature, there are no studies evaluating the effects of ground-based walking training in PH patients.

Conditions

Pulmonary Hypertension

Keywords

Pulmonary Hypertension; Walking Training; Exercise; Balance; Quality of Life

Outcome Measures

Primary Outcomes (1)

• Endurance exercise capacity

  endurance shuttle walk test

  8 weeks

Study Arms (2)

Training Group

EXPERIMENTAL

Training group will attend ground-based walking training under the supervision of a physiotherapist for 2 days and 30 minutes a week. Patients will walk for 1-2 days in a week without supervision.

Other: Ground-based walking training

Control Group

NO INTERVENTION

Patient education will be given and no intervention will be made.

Interventions

Ground-based walking training OTHER

Patients will attend a 2-day 30-minute ground-based walking training under the supervision of a physiotherapist. Patients will walk for 1-2 days in a week without supervision. According to the Modified Borg Scale, the dyspnea intensity will be 3-4 (medium to slightly difficult) and the heart rate will be completed to not exceed 120 min / pulse. Heart rate of patients will be followed by finger type pulse oximeter

Training Group

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years
• Diagnosed with PH
• Followed by the department of chest diseases at least six months
• Not participating in the rehabilitation program in last year

You may not qualify if:

• Functional group four due to WHO functional classification
• PH due to left heart diseases, PH due to lung diseases and/or hypoxia
• Treatment and medication change in the last three months
• Cooperation problems
• Patients with successful pulmonary endarterectomy operation
• Smoking
• Patients with uncontrolled cardiovascular diseases
• Patients with orthopeadic and/or neurologic disorders that could limit exercise tests
• Syncope history in recent

Sponsors & Collaborators

• Istanbul University: lead

Study Sites (1)

Ozge Ertan

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hypertension, Pulmonary; Motor Activity

Condition Hierarchy (Ancestors)

Lung Diseases; Respiratory Tract Diseases; Hypertension; Vascular Diseases; Cardiovascular Diseases; Behavior

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Physiotherapist

Study Record Dates

• First Submitted: November 28, 2018
• First Posted: December 3, 2018
• Study Start: December 10, 2018
• Primary Completion: March 4, 2020
• Study Completion: March 4, 2020
• Last Updated: March 25, 2020

Record last verified: 2020-03

Locations

TU (1)